Daehan New Pharm Co. Ltd (054670) — Cash Flow Reinvestment Rate
Daehan New Pharm Co. Ltd (054670) has a Cash Flow Reinvestment Rate of 2.61x as of September 2025, reinvesting ₩11.53 Billion (capex ₩11.53 Billion ) from operating cash flow of ₩4.43 Billion. Explore 054670 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Daehan New Pharm Co. Ltd Cash Flow Reinvestment Rate (2011–2024)
Historical reinvestment intensity for Daehan New Pharm Co. Ltd across 12 annual periods. Also explore 054670 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Daehan New Pharm Co. Ltd (2011–2024)
Year-by-year capital reinvestment analysis for Daehan New Pharm Co. Ltd. For live market cap and broader valuation context, see 054670 company net worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.35x | ₩63.38 Billion | ₩18.95 Billion | ₩34.26 Billion | ▲ +89.1% |
| 2023 | 1.77x | ₩22.23 Billion | ₩12.57 Billion | ₩9.93 Billion | ▲ +141.5% |
| 2022 | 0.73x | ₩10.44 Billion | ₩14.25 Billion | ₩3.51 Billion | ▼ -50.4% |
| 2021 | 1.48x | ₩24.48 Billion | ₩16.58 Billion | ₩10.55 Billion | ▲ +30.2% |
| 2020 | 1.13x | ₩15.36 Billion | ₩13.55 Billion | ₩9.46 Billion | ▲ +176.9% |
| 2019 | 0.41x | ₩9.38 Billion | ₩22.89 Billion | ₩9.08 Billion | ▲ +372.5% |
| 2018 | 0.09x | ₩1.77 Billion | ₩20.47 Billion | ₩1.73 Billion | ▼ -90.5% |
| 2016 | 0.91x | ₩7.96 Billion | ₩8.75 Billion | ₩4.57 Billion | ▲ +81.6% |
| 2015 | 0.50x | ₩3.91 Billion | ₩7.80 Billion | ₩3.86 Billion | ▼ -28.2% |
| 2014 | 0.70x | ₩6.99 Billion | ₩10.02 Billion | ₩6.69 Billion | ▼ -88.4% |
| 2012 | 6.00x | ₩1.54 Billion | ₩256.82 Million | ₩1.24 Billion | ▲ +1330.2% |
| 2011 | 0.42x | ₩1.43 Billion | ₩3.42 Billion | ₩1.20 Billion | — |